Final phase II data support safety of picoplatin as alternative to oxaliplatin in metastatic CRC Feb. 1, 2010
siRNA-nanosome formulations inhibit HCV RNA replication in interferon-resistant replicon cells Jan. 15, 2010
Phase III studies show comparable efficacy with albinterferon alfa-2b vs. peginterferon alfa-2a Jan. 14, 2010
Durable viral suppression seen with MK-7009 combination therapy in patients with hepatitis C Jan. 14, 2010
RSS